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Short-lasting unilateral neuralgiform headache with con-
junctival injection and tearing (SUNCT) syndrome is an
infrequent form of unilateral headache accompanied by
cranial autonomic features [1]. The pain is severe, and the
titrations of some of the drugs have to be slow to prevent
side effects [2, 3]. We present a case of a patient with
SUNCT syndrome who showed a temporal improvement of
pain with bupivacaine greater occipital nerve (GON) block.
A 82-year-old woman was admitted because of recent
onset of facial pain. Intense attacks of periocular left pain,
lasting for 2 min, had started 3 days previously. She also
experienced conjunctival injection and lacrimation during
the attacks. She suffered from 10 to 20 attacks per day. The
neurological examination was absolutely normal, except
that touching the left forehead triggered the pain without
any refractory period. In the emergency room, with the
suspicion of trigeminal neuralgia, she was prescribed car-
bamazepine 600 mg daily for a week, phenytoin 300 mg
daily for a week and tramadol 100 mg for 4 days, without
any improvement. After a headache unit evaluation the
diagnosis of SUNCT was made and we put the patient on
lamotrigine and gabapentin with slow titration. Because the
patient was suffering from intense pain we decided to
prove a bupivacaine GON block; she was asymptomatic for
48 h. After 2 weeks she started with gabapentin 1,800 mg
and lamotrigine 75 mg daily. The pain attacks improved
and in one more week she became asymptomatic.
The response of SUNCT to intravenous lidocaine has
been described previously [4]. Intravenous lidocaine per-
fusion carries risks, especially in the elderly [4]. GON
block has been used in several primary headaches, such as
migraine, cluster headache and hemicrania continua. Some
studies show that GON block could change trigeminal
activity [5]. GON block is a safe therapy and could be an
option for alleviation of SUNCT pain during oral drugs
titration.
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